Bottom line
How much do JDOC and SCHLX overlap?
65% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 59.6% of JDOC's assets and 59.4% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings JDOC and SCHLX have in common
| Holding | % of JDOC | % of SCHLX | Overlap |
|---|---|---|---|
| AbbVie, Inc. | 7.85% | 4.90% | 4.90% |
| Eli Lilly & Co. | 7.76% | 13.85% | 7.76% |
| UnitedHealth Group, Inc. | 5.85% | 5.73% | 5.73% |
| Merck & Co., Inc. | 4.82% | 4.85% | 4.82% |
| Johnson & Johnson | 4.82% | 6.19% | 4.82% |
| AstraZeneca plc | 3.76% | 3.80% | 3.76% |
| Thermo Fisher Scientific, Inc. | 3.73% | 3.46% | 3.46% |
| Bristol-Myers Squibb Co. | 3.57% | 1.50% | 1.50% |
| Abbott Laboratories | 3.11% | 2.39% | 2.39% |
| Roche Holding AG | 2.82% | 1.24% | 1.24% |
| Stryker Corp. | 2.23% | 2.61% | 2.23% |
| Danaher Corp. | 2.16% | 2.13% | 2.13% |
| Cencora, Inc. | 2.07% | 1.26% | 1.26% |
| Intuitive Surgical, Inc. | 1.93% | 2.69% | 1.93% |
| Regeneron Pharmaceuticals, Inc. | 1.60% | 1.43% | 1.43% |
| Cardinal Health, Inc. | 1.51% | 1.34% | 1.34% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in JDOC
- CVS Health Corp. — 2.83%
- Novo Nordisk A/S — 2.61%
- GSK plc — 2.47%
- Argenx SE — 2.06%
- Edwards Lifesciences Corp. — 1.73%
- IQVIA Holdings, Inc. — 1.71%
- Teva Pharmaceutical Industries Ltd. — 1.60%
- Novartis AG — 1.60%
- Biogen, Inc. — 1.56%
Only in SCHLX
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
- Vertex Pharmaceuticals Inc — 2.45%
- Boston Scientific Corp — 2.10%
- McKesson Corp — 2.05%
- Novo Nordisk A/S — 1.73%
- Medtronic PLC — 1.54%
- Pfizer Inc — 1.17%
Asset mix
| Asset type | JDOC | SCHLX |
|---|---|---|
| Stocks | 99.2% | 99.6% |
| Cash & short-term funds | — | 0.5% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Country mix
| Country | JDOC | SCHLX |
|---|---|---|
| US | 75.2% | 85.7% |
| GB | 6.2% | 3.8% |
| CH | 4.4% | 5.2% |
| DK | 4.0% | 1.7% |
| JP | 2.5% | — |
| NL | 2.4% | 1.0% |
| DE | 1.9% | — |
| IL | 1.6% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do JDOC and SCHLX overlap?
What stocks do JDOC and SCHLX have in common?
Should I own both JDOC and SCHLX?
Which holds more stocks, JDOC or SCHLX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.